Start a New Search
SHOWING 71 RESULTS
In the US, ketamine is currently a Schedule III drug under the Controlled Substances Act, and strict regulations and safeguards are already in place to prevent its illegal use.
Research Administration & Regulation | Reducing Regulatory Burden | Higher Education Regulation | LettersComments on OSTP Memorandum, “Increasing Access to the Results of Federally Funded Scientific Research,” May 14, 2013.
Intellectual Property | Public/Open Access | Reducing Regulatory Burden | StatementsComments regarding RFI offering principal investigators with Federal research funding the opportunity to identify regulations contributing most to their administrative workload, and offering recommendations for reducing them.
Research Administration & Regulation | Reducing Regulatory Burden | LettersAt the request of NRC, COGR, AAU, and APLU have assembled ten recommendations for regulatory reform improving research universities’ ability to carry out their missions with minimum financial investment by the Fed.
Research Administration & Regulation | Reducing Regulatory Burden | Innovation and Competitiveness | RecommendationRegulatory and reporting requirements have become excessively burdensome, a more balanced approach is needed.
Research Administration & Regulation | Costs of Research (F&A Costs) | Science & Security | Reducing Regulatory Burden | Export Controls | Innovation and Competitiveness | Articles & Op-EdsComments OMB proposed guidance, "Reform of Federal Policies Relating to Grants and Cooperative Agreements; Cost Principles and Administrative Requirements (Including Single Audit Act)."
Research Administration & Regulation | Costs of Research (F&A Costs) | Reducing Regulatory Burden | LettersIt is imperative that we work to ensure efficiency in government regulation to reduce the costs of compliance and to maximize the productivity of researchers.
Research Administration & Regulation | Costs of Research (F&A Costs) | Reducing Regulatory Burden | LettersThe Association of American Universities (AAU), representing 61 leading public and private research universities, would like to thank the Office of Science and Technology Policy (OSTP) for this opportunity to provide comments on the Bioeconomy Blueprint.
Innovation and Competitiveness | National Institutes of Health | Technology Transfer | Costs of Research (F&A Costs) | Reducing Regulatory Burden | Research Administration & Regulation | LettersThe purpose of this survey was to document the administrative impact of ARRA on each institutional member of the Federal Demonstration Partnership.
Research Administration & Regulation | Costs of Research (F&A Costs) | Reducing Regulatory Burden | ReportsJoint statement by AAU, APLU, and COGR on the Digital Accountability and Transparency (DATA) Act of 2011.
Research Administration & Regulation | Costs of Research (F&A Costs) | Reducing Regulatory Burden | Statements